quasi architebeat vitae dicta sunt explicabo nemo enim ipsam voluptatem quia voluptassit.
x
Koushik Chakrabarty, PhD
Principal Investigator koushik@narayananethralaya.com080 66660712
Curriculum Vitae
About Narayana Nethralaya Foundation
Reliable Agroscience & Soil Analysis Research.
Excepteur sint occaecat cupidatat non proident sunt culpa qui officia deserunt mollit anim id est laborum. sed spiciatis unde omnis natus error Inventore.
Medical Research
Excepteur sint ocecat pro dent sunt in culpa qui.
Blood Resources
Excepteur sint ocecat pro dent sunt in culpa qui.
Clinical Services
Explore Our Main Services.
Clinical Microbiology
Tests
Excepteur sint ocecat pro sunt in culpa. qui officia deserunt mollit anim id est. perspiciatis unde.
Testing for Traces &
Impurities
Excepteur sint ocecat pro sunt in culpa. qui officia deserunt mollit anim id est. perspiciatis unde.
Clinical Biochemistry
Tests
Excepteur sint ocecat pro sunt in culpa. qui officia deserunt mollit anim id est. perspiciatis unde.
0+
Permanent Staff
0k+
Test Completed
0+
Wining Awards
0k+
Years Of Exps.
Testimonials
What Our Patient Say?
Lorem ipsum dolor amet consectet adipiscing sed do eiusmod tempor incidunt labore dolor magna aliqua ipsum suspen disse.
Robert Downey
New YorkLorem ipsum dolor amet consectet adipiscing sed do eiusmod tempor incidunt labore dolor magna aliqua ipsum suspen disse.
Robert Downey
New YorkLorem ipsum dolor amet consectet adipiscing sed do eiusmod tempor incidunt labore dolor magna aliqua ipsum suspen disse.
Robert Downey
New YorkTeam Member
Focusing Your Mind, with The
Best Expert.
Dr. Gerard Butler
PHD StudentResearch Interests
Our research focuses are on iPSC based disease modelling and translation to cell therapy. We generate personalised patient derived iPSCs lines and derive corneal and retinal cell lineages and organoids to investigate the molecular mechanisms involved in corneal dystrophies and inherited retinal diseases. Towards our translation goals, we derive corneal lineage cells from iPSCs and develop protocols towards enhancing their banking for future clinical application.
Select Publications
- Chakrabarty K, et al. Generation of iPSC line (GLNNFi001-A) from peripheral blood mononuclear cells of a patient with macular corneal dystrophy. Stem Cell Res. 2022 Apr 22;62:102789.
- Chakrabarty K, Shetty R, Ghosh A. iPSC-based disease modeling and prospective immune therapy for COVID-19, Cytotherapy, Sept ( 2021).
- Vinekar A, Nair AP, Sinha S, Vaidya T, Chakrabarty K, et al. Tear Fluid Angiogenic Factors: Potential Noninvasive Biomarkers for Retinopathy of Prematurity Screening in Preterm Infants. Invest Ophthalmol Vis Sci. 2021 Mar 1;62(3):2.
- Shetty R, Murugeswari P, Chakrabarty K, et al. Stem cell therapy in coronavirus disease 2019: current evidence and future potential. Cytotherapy. 2020 Nov 9:S1465-3249(20)30932-4.
- Shetty R, Naidu JR, .., Chakrabarty K. Distinct ocular surface soluble factor profile in human corneal dystrophies. Ocul Surf. 2019 Nov 19. Corresponding author
- Chakrabarty K, Shetty R, Ghosh A. Corneal cell therapy: with iPSCs, it is no more a far-sight. Stem Cell Res Ther. 2018 Oct 25;9(1):287. Corresponding author